Table 2.
Comparison of idarubicin and daunorubicin in induction in younger patients
NR indicates not reported.
*Patients age 50–70 years.
Comparison of idarubicin and daunorubicin in induction in younger patients
NR indicates not reported.
*Patients age 50–70 years.
